- Midostaurin - the First Targeted Therapy Drug for Patients with Acute Myeloid Leukaemia with FLT3 Mutation2022 | First Faculty of Medicine
- Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)2007 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | First Faculty of Medicine
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 982010 | Second Faculty of Medicine
- Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? : an analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT)2007 | First Faculty of Medicine
- Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria2010 | First Faculty of Medicine
- Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping2023 | First Faculty of Medicine
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Faculty of Pharmacy in Hradec Králové